Neuropsychology in the Corona Pandemic and Beyond DOI
Martin Peper, Juliana Kolano, Catherine Widmann

et al.

Zeitschrift für Neuropsychologie, Journal Year: 2023, Volume and Issue: 34(2), P. 53 - 55

Published: May 24, 2023

Language: Английский

Subjective and Objective Cognitive Deficits in Patients with Post-COVID Syndrome DOI Creative Commons
Ann‐Katrin Schild, Daniel Scharfenberg, Lukas Kirchner

et al.

Zeitschrift für Neuropsychologie, Journal Year: 2023, Volume and Issue: 34(2), P. 99 - 110

Published: May 24, 2023

Abstract: Cognitive impairment is a prominent symptom of the post-COVID syndrome (PCS). However, correspondence between subjective cognitive complaints (SCC) and objective results inconsistent. Here, we investigated this discrepancy. This longitudinal study included N = 42 individuals who reported SCC as PCS after mild infection at inclusion. Data collection comprised questionnaires neuropsychological assessment baseline follow-up (FU). At FU – on average 15 months acute COVID-19 88 % patients persisting SCC. There was an approx. 40 discrepancy report test both visits. Patients with indicated elevated fatigue reduced quality life compared to without FU. A growing number anticipated request assessments even infections.

Language: Английский

Citations

14

Long COVID: neurological manifestations - an updated narrative review DOI Creative Commons
José Wagner Leonel Tavares-Júnior, Gabriella Cunha Vieira Ciurleo, Alissa Moura Formiga

et al.

Dementia & Neuropsychologia, Journal Year: 2024, Volume and Issue: 18

Published: Jan. 1, 2024

ABSTRACT. Infection with the SARS-CoV-2 virus can lead to neurological symptoms in acute phase and Long COVID phase. These usually involve cognition, sleep, smell disorders, psychiatric manifestations, headache others. This condition is more commonly described young adults women. symptomatology follow severe or mild cases of disease. The importance this issue resides high prevalence phase, which entails significant morbidity population. In addition, such a associated health care costs, some estimates hovering around 3.7 trillion US dollars. review, we will sequentially describe current knowledge about most prevalent COVID, as well their pathophysiology possible biomarkers.

Language: Английский

Citations

5

What We Know About Neurocognitive Outcomes in Long-/Post-COVID-19 Adults DOI Creative Commons
Susan Seibert, Alexander Hanke, Michelle Wieberneit

et al.

Zeitschrift für Neuropsychologie, Journal Year: 2024, Volume and Issue: 35(2), P. 63 - 76

Published: May 1, 2024

Abstract: This review assesses neurocognitive studies on long-/post-COVID-19 adult patients, highlighting the research gaps. We categorize populations by infection severity, demographics, inclusion of controls, and psychological/biological factors. Methodologically, we analyzed 73 (95,600 subjects) from December 2019 to October 2022 using PRISMA-ScR guidelines PICO framework. Our findings revealed that most lacked control groups (88 %) reported unclear overall cognitive outcomes (73 %). While frequently assessed executive functions (86 attention (85 %), there were few longitudinal studies. Varied reporting sample sizes further complicated analysis. The identified gaps encompass convenience sampling, limited studies, inadequate use test batteries, leading a discrepancy between expected outcomes. absence standardized comparisons inconsistent statistical methods exacerbated these

Language: Английский

Citations

4

Six-month follow-up of multidomain cognitive impairment in non-hospitalized individuals with post-COVID-19 syndrome DOI Creative Commons
Ann‐Katrin Schild, Daniel Scharfenberg, Anton Regorius

et al.

European Archives of Psychiatry and Clinical Neuroscience, Journal Year: 2024, Volume and Issue: 274(8), P. 1945 - 1957

Published: July 24, 2024

Abstract Some people infected with SARS-CoV-2 report persisting symptoms following acute infection. If these persist for over three months, they are classified as post-COVID-19 syndrome (PCS). Although PCS is frequently reported, detailed longitudinal neuropsychological characterization remains scarce. We aimed to describe the trajectory of cognitive and neuropsychiatric symptoms. 42 individuals deficits after asymptomatic mild/moderate COVID-19 at study inclusion received assessment baseline (BL) follow-up (FU; six months BL). Assessments included comprehensive testing five neurocognitive domains, two screening tests, questionnaires on depression, anxiety, sleep, fatigue, health-related quality life. Results showed high rates subjective complaints BL FU (95.2% versus 88.1%) without significant change time. However, objectively measured disorder (NCD) decreased (61.9% 42.9%). All domains were affected, yet most found in learning memory, followed by executive functions, complex attention, language, perceptual motor functions. In NCD, first mentioned improved significantly time, while last remained unchanged. Cognitive tests did not prove valuable detecting impairment. Neuropsychiatric constant except life, which improved. This emphasizes importance research provides insights into long-term impairments PCS. While performance many

Language: Английский

Citations

4

The Leipzig Treatment Program for Interdisciplinary Diagnosis and Therapy of Neurocognitive Post-COVID Symptoms DOI Creative Commons

Anna S. Hasting,

Sabine Herzig,

Hellmuth Obrig

et al.

Zeitschrift für Neuropsychologie, Journal Year: 2023, Volume and Issue: 34(2), P. 71 - 83

Published: May 24, 2023

Abstract: This study introduces a 3-week group program designed for patients with neurocognitive post-COVID-19 syndrome (PCS). The represents combination of evidence-based components neurorehabilitation and cognitive behavioral therapy (CBT). Following detailed assessment, we develop personalized bio-psycho-social model that integrates perceived complaints identifies modifiable influencing factors. We employed physiotherapeutic, cognitive, communicative training methods to improve patients’ awareness energy limits implement compensatory strategies, including pacing mindfulness techniques. N = 33 completed the between June 2021 November 2022. A pre-post comparison questionnaire-based self-assessments revealed significant positive effects on mood, self-efficacy, participation but not fatigue symptoms. provides recommendations neuropsychological treatment PCS.

Language: Английский

Citations

9

Effects of Perceived COVID-19 Exposure and Action-Outcome Predictability on the Motivation to Invest Cognitive Effort DOI Creative Commons
Juliana Kolano, Devdath Kishore Menon, Martin Peper

et al.

Zeitschrift für Neuropsychologie, Journal Year: 2024, Volume and Issue: 35(2), P. 89 - 103

Published: May 1, 2024

Abstract: Everyday life situations characterized by poor controllability because of restrictions and uncertainty about action outcomes may attenuate motivational states executive control. This article explores the interaction a prior experience with COVID-19 susceptibility to respond challenging situation low action-outcome predictability. We assessed cognitive effort readiness as willingness invest in cognitively demanding tasks. Individuals history exhibited more pronounced reduction after experiencing experimentally induced unpredictability compared controls. These results suggest generalization perceived loss control among individuals history. findings contribute conceptualizing assessing long-term consequences pandemic-induced emotional problems.

Language: Английский

Citations

2

The Importance of Neuropsychology in the Early Rehabilitation of Patients with Critical Illness after Acute COVID Infection DOI
Petra Maurer-Karattup,

Luzie Rost

Zeitschrift für Neuropsychologie, Journal Year: 2023, Volume and Issue: 34(2), P. 85 - 97

Published: May 24, 2023

Abstract: The current literature has insufficiently examined the potential benefits of implementing early neuropsychological interventions for critically ill patients who have experienced COVID-19. To address this research gap, we conducted a descriptive analysis clinical and data from N = 29 with COVID-19 admitted to an neurological rehabilitation facility. Most had been diagnosed critical illness polyneuropathy (CIP), one-third exhibited additional brain damage. Upon admission, all severe cognitive impairments, demonstrating significant improvement following therapy. Nonetheless, neurocognitive outcomes at discharge displayed high psychoemotional status variability. This paper presents treatment concept employed discusses challenges encountered while treating impairments.

Language: Английский

Citations

4

Neuropsychologische Begutachtung bei COVID-19-assoziierten Erkrankungen DOI
Gordon Hendrik Krahl, Steffen Aschenbrenner, Jutta Billino

et al.

Zeitschrift für Neuropsychologie, Journal Year: 2024, Volume and Issue: 35(2), P. 105 - 114

Published: May 1, 2024

Zusammenfassung: Die neuropsychologische Begutachtung von Personen nach Infektionen mit der Coronavirus-Krankheit 2019 (COVID-19) und potenziellen Symptomen des Post-COVID-Syndroms (PCS) im sozialrechtlichen Kontext erfordert nicht nur die Einhaltung spezifischer rechtlicher Vorgaben, sondern auch Berücksichtigung allgemeiner Leitlinien Fachgesellschaften. PCS-Begutachtung stellt sowohl für Betroffene als Gutachter Gutachterinnen eine Herausforderung dar, wenn Funktionsdefizite oder Kausalzusammenhänge eindeutig sind. Dieser Artikel vermittelt einen Überblick über relevante Forschungsergebnisse zur Pathogenese reflektiert aktuelle Rahmenbedingungen Beurteilungsregularien. sollte sich in Deutschland an den Gesellschaft Neuropsychologie (GNP) orientieren, sind publizierten neurologischen Kriterien zu integrieren. Mit raschem Fortschreiten PCS-Forschung hohen interdisziplinären Anforderungen ist ein fachlicher Austausch wesentlich, um Standards neuropsychologischen PCS weiterzuentwickeln.

Citations

1

Impacts of COVID-19 on mental health DOI
Markus Hayden

Zeitschrift für Pneumologie, Journal Year: 2024, Volume and Issue: unknown

Published: Aug. 6, 2024

Language: Английский

Citations

1

Folgen von COVID-19 für die psychische Gesundheit DOI
Markus Hayden

Zeitschrift für Pneumologie, Journal Year: 2024, Volume and Issue: 21(4), P. 248 - 255

Published: June 14, 2024

Citations

0